<< View other programs for patients and families.

2026 Seminar for Patients - Recordings and Transcripts

When is treatment needed for HCL and HCL variant (HCLv)? What are my options? What can I expect during recovery? Explore the sessions from our 2026 seminar for answers to these questions, practical nutrition tips, and an introduction to the HCL Patient Data Registry. Watch the recordings at your own pace, read the transcripts, or browse the audience Q&A.

How to Explore Each Session

  • Meet the speaker: Click the down arrow (⌄) next to the speaker’s name to read their biography.

  • Explore key takeaways: Read the introduction and highlights for a quick overview of the presentation.

  • Watch or read: Choose how you prefer to explore the session — watch the video (▶) or click the down arrow (⌄) below it to read the full transcript.

  • Explore the Q&A: Click the down arrow (⌄) next to the Q&A section to read questions and answers.

  • Listen to the expert panel: Click the play button (▶) on any audio recording to hear the doctors share their perspectives.

  • Video captions: The video format provides AI-generated captions that occasionally contain errors. For the most accurate text, view the transcript below each presentation. Each transcript has been reviewed by HCLF staff to ensure it reflects the presenter’s remarks accurately.

  • Note: The 2026 patient seminar was a hybrid meeting, with speakers and some patients and families participating in person, and many more individuals participating online. The recordings are of a live, in-person event, and listeners might detect minor microphone interference or background noise.


Deepening Your Knowledge of HCL and HCLv

Whether you're newly diagnosed, preparing for treatment, or looking to better understand your options, these expert-led sessions offer clear, practical information about HCL and HCLv. Learn about the disease, explore treatment approaches, and hear how specialists make care decisions based on each person's needs and circumstances.

Understanding Hairy Cell Leukemia

Dr. Kerry Rogers, The Ohio State University

Dr. Kerry Rogers explains the basics of HCL, including how it is diagnosed, when treatment may be needed, and why some people can be monitored without treatment. She also explains remission, relapse, and measurable residual disease (MRD) in terms that help people living with HCL and their families better understand conversations about their care.

Key Takeaways:

  • HCL is rare, but the outlook is often reassuring.

  • Treatment is not always needed right away.

  • Blood counts and symptoms help guide treatment decisions.

  • Remission can be complete or partial, meaning that the signs of HCL have disappeared or decreased after treatment.

  • Relapse does not automatically mean immediate treatment.

  • MRD testing looks for very small amounts of remaining leukemia.

View a recording of Dr. Rogers’ presentation below.


Preparing for Treatment and Recovery

Dr. Versha Banerji, CancerCare Manitoba

Dr. Versha Banerji offers a practical guide to preparing for HCL treatment and recovering afterward. She explains what to expect during monitoring and treatment, how to reduce infection risks, when to contact your care team, and how to plan for work, travel, and everyday life. The presentation also highlights the importance of preventive care, emotional support, and allowing time for recovery.

Key Takeaways:

  • Monitoring is an active part of care.

  • Treatment decisions are personal.

  • Plan ahead where possible.

  • Infection prevention is a shared effort.

  • Fever during treatment needs urgent attention.

  • Recovery takes time.

  • Care continues after treatment.

View a recording of Dr. Banerji’s presentation below.


Treatment Today: Making Sense of Your Options

Dr. Seema Bhat, The Ohio State University

Dr. Seema Bhat explains how doctors decide when to treat hairy cell leukemia (HCL) and how they choose among treatment options. She compares established treatments with targeted medicines, discusses how side effects and personal preferences can shape the decision, and shares what researchers are studying in clinical trials.

Key takeaways:

  • Some people can start with monitoring blood counts and symptoms over time to decide when treatment may be needed.

  • Your health and preferences help shape the plan.

  • Cladribine and pentostatin remain important treatments for classic HCL.

  • Targeted medicines can be useful in selected situations.

  • Clinical trials are exploring more options.

  • Bring questions to your doctor’s appointment.

View a recording of Dr. Bhat’s presentation below.


Treatment Today: Expert Panel Discussion (to listen to the audio, click ▶)

Following Dr. Bhat’s presentation, she facilitated a panel discussion with Dr. Robert Kreitman, Dr. Michael Grever, and Dr. Jae Park. You can listen to her opening remarks for the panel discussion and to each speaker’s initial remarks. A full transcript of the expert panel is also available.

Opening the Expert Panel: Perspectives on HCL Treatment
Dr. Seema Bhat
Dr. Robert Kreitman (4:56 min)
National Cancer Institute - NIH
Dr. Michael Grever (4:52 min)
The Ohio State University
Dr. Jae Park (3:28 min)
Memorial Sloan Kettering Cancer Center

Living with Hairy Cell Leukemia

Living with HCL or HCLv involves more than medical treatment. Discover how nutrition, balanced eating, food safety, and everyday habits can support your health and well-being. This session offers practical guidance to help you manage common challenges, maintain your strength, and make informed choices throughout your HCL journey.

 

NUTRITION AND DIET FOR PATIENTS

Ernestine Trujillo, MS, RD, LD, UNM Comprehensive Cancer Center

Registered dietitian Ernestine Trujillo shares practical ways for people living with HCL or HCLv to ensure adequate nutrition before, during, and after treatment. She covers small meals and snacks, hydration, food safety when your immune system is weakened, and ways to adapt your meals when side effects get in the way.

Key takeaways

  • Make room for a variety of foods to help meet your energy and nutrition needs.

  • Adapt meals to how you feel.

  • Pay attention to fluids, calories, and protein.

  • Handle food carefully when your immune system is weakened.

  • Check with your care team before taking supplements.

  • Ask for help with fatigue.

View a recording of Ms. Trujillo’s presentation below.


Hairy Cell Leukemia Research

Every person's experience with HCL or HCLv can help advance our understanding of this rare disease. Learn how the HCL Patient Data Registry brings together information from people living with HCL and HCLv to support research, explore treatment outcomes, and improve future care. Discover how the registry works, how your information is protected, and how you can contribute to research that benefits the entire HCL community.

 

Overview of the HCL Patient Data Registry

Speaker: Mirela Anghelina, MD, MPH, The Ohio State University

Dr. Anghelina explains what the HCL Patient Data Registry collects, how researchers use that information, and what to expect if you’re interested in joining. The audience Q&A covers how participation works in the United States and internationally.

Key takeaways

  • The registry helps researchers learn from people’s experiences with HCL and HCLv. Projects explore treatment outcomes, quality of life, and how experiences differ across groups.

  • Participation is voluntary.

  • Researchers request only the data they need for an approved project. They submit a proposal and specify the information needed to answer their research question.

View a recording of Dr. Anghelina’s presentation below.


Support the HCL Community

Donations help the Hairy Cell Leukemia Foundation (HCLF) provide patient education, community programs, reliable resources, and support for research. Every contribution helps strengthen the HCL and HCLv community and advance progress for all patients and families.

Our Mission

The Hairy Cell Leukemia Foundation (HCLF) is the only nonprofit organization in the United States dedicated to HCL. The HCLF seeks to improve patient outcomes by funding research and providing patients with access to educational resources and peer-to-peer support.

We work alongside patients, families, and researchers to advance knowledge and strengthen support for everyone affected by HCL.

Most HCLF board members are HCL survivors, and HCLF programs are designed and implemented with patient input. An advisory board composed of hematologists from among the world's leading cancer centers provides clinical expertise for our patient education programs and research initiatives.